36 related articles for article (PubMed ID: 34864525)
1. Cost-effectiveness of oral cancer screening: results from a cluster randomized controlled trial in India.
Subramanian S; Sankaranarayanan R; Bapat B; Somanathan T; Thomas G; Mathew B; Vinoda J; Ramadas K
Bull World Health Organ; 2009 Mar; 87(3):200-6. PubMed ID: 19377716
[TBL] [Abstract][Full Text] [Related]
2. Prevalence and risk factors of oral potentially malignant disorders in Indonesia: a cross-sectional study undertaken in 5 provinces.
Sari EF; Johnson NW; McCullough MJ; Cirillo N
Sci Rep; 2024 Mar; 14(1):5232. PubMed ID: 38433259
[TBL] [Abstract][Full Text] [Related]
3. Development and Validation of Risk Models to Select Ever-Smokers for CT Lung Cancer Screening.
Katki HA; Kovalchik SA; Berg CD; Cheung LC; Chaturvedi AK
JAMA; 2016 Jun; 315(21):2300-11. PubMed ID: 27179989
[TBL] [Abstract][Full Text] [Related]
4. Risk-Based Selection of Individuals for Oral Cancer Screening.
Cheung LC; Ramadas K; Muwonge R; Katki HA; Thomas G; Graubard BI; Basu P; Sankaranarayanan R; Somanathan T; Chaturvedi AK
J Clin Oncol; 2021 Feb; 39(6):663-674. PubMed ID: 33449824
[TBL] [Abstract][Full Text] [Related]
5. Applying the National Lung Screening Trial eligibility criteria to the US population: what percent of the population and of incident lung cancers would be covered?
Pinsky PF; Berg CD
J Med Screen; 2012 Sep; 19(3):154-6. PubMed ID: 23060474
[TBL] [Abstract][Full Text] [Related]
6. Lung cancer risk by years since quitting in 30+ pack year smokers.
Pinsky PF; Zhu CS; Kramer BS
J Med Screen; 2015 Sep; 22(3):151-7. PubMed ID: 25926339
[TBL] [Abstract][Full Text] [Related]
7. Cost-Effectiveness Analysis of Lung Cancer Screening in the United States: A Comparative Modeling Study.
Criss SD; Cao P; Bastani M; Ten Haaf K; Chen Y; Sheehan DF; Blom EF; Toumazis I; Jeon J; de Koning HJ; Plevritis SK; Meza R; Kong CY
Ann Intern Med; 2019 Dec; 171(11):796-804. PubMed ID: 31683314
[TBL] [Abstract][Full Text] [Related]
8. Modeling oral cancer screening in the United States population.
Cramer JD; Grauer J
Oral Oncol; 2022 Jan; 124():105656. PubMed ID: 34864525
[TBL] [Abstract][Full Text] [Related]
9. Oral cancer screening: what have we learnt and what is there still to achieve?
Brocklehurst PR; Baker SR; Speight PM
Future Oncol; 2010 Feb; 6(2):299-304. PubMed ID: 20146588
[TBL] [Abstract][Full Text] [Related]
10. Screening for oral cancer: Future prospects, research and policy development for Asia.
Nagao T; Warnakulasuriya S
Oral Oncol; 2020 Jun; 105():104632. PubMed ID: 32315954
[TBL] [Abstract][Full Text] [Related]
11.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
